v3.25.3
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Oct. 31, 2025
Oct. 31, 2024
Operating activities:        
Net income (loss) $ 4,271 $ (14,403) $ 1,011 $ (52,137)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation and amortization 7,478 7,087 21,765 21,063
Stock-based compensation expense 15,959 16,525 49,414 49,813
Amortization of deferred financing costs and debt discount 61 62 185 174
Cost of Phreesia hardware purchased by customers 235 571 828 1,248
Deferred contract acquisition costs amortization 111 1,322 463 1,706
Non-cash operating lease expense 224 207 657 568
Deferred taxes 57 57 (1,441) 176
Changes in operating assets and liabilities:        
Accounts receivable (11,455) (10,141) (14,765) (6,558)
Prepaid expenses and other assets (1,952) 1,005 (4,868) 4,286
Deferred contract acquisition costs 0 (552) (351) (765)
Accounts payable 1,303 6,948 1,632 5,198
Accrued expenses and other liabilities (3,452) (3,655) (5,632) (6,202)
Lease liabilities (242) (202) (732) (622)
Deferred revenue 2,869 954 (3,014) (1,823)
Net cash provided by operating activities 15,467 5,785 45,152 16,125
Investing activities:        
Capitalized internal-use software (3,395) (3,566) (10,718) (11,112)
Purchases of property and equipment (3,271) (616) (8,542) (5,919)
Net cash used in investing activities (6,666) (4,182) (19,260) (17,031)
Financing activities:        
Proceeds from issuance of common stock upon exercise of stock options 838 17 1,080 583
Proceeds from employee stock purchase plan 632 840 1,975 2,443
Finance lease payments (1,783) (1,895) (5,669) (5,170)
Principal payments on financing agreements (336) (304) (984) (888)
Debt issuance costs and loan facility fee payments (18) 0 (56) (152)
Financing payments of acquisition-related liabilities 0 (309) 0 (1,673)
Net cash used in financing activities (667) (1,651) (3,654) (4,857)
Effect of exchange rate changes on cash and cash equivalents (29) (10) (87) (17)
Net increase (decrease) in cash and cash equivalents 8,105 (58) 22,151 (5,780)
Cash and cash equivalents – beginning of period 98,266 81,798 84,220 87,520
Cash and cash equivalents – end of period 106,371 81,740 106,371 81,740
Supplemental information of non-cash investing and financing information:        
Right of use assets acquired in exchange for operating lease liabilities 0 0 0 1,958
Property and equipment acquisitions through finance leases 0 6,847 0 13,709
Purchase of property and equipment and capitalized software included in current liabilities 879 3,508 879 3,508
Capitalized stock-based compensation 312 343 964 1,006
Issuance of stock to settle liabilities for stock-based compensation 3,880 2,853 11,734 10,679
Cash paid for:        
Interest 239 595 893 1,459
Income taxes $ 334 $ 549 $ 1,648 $ 2,559